Empowering investors with access to the best research, experts and opportunities.
Before becoming a portfolio manager with Perennial Partners, Samuel Berridge had studied to be a geologist and chemist – the latter teaching him skills he thought little of at the time.
Australia’s spending on major infrastructure projects is at record levels and expected to keep growing, creating new jobs and opportunities for local businesses.
Australian Internet of Things business TZ has won a series of new Australian contracts worth more than $1 million, with new CEO Mario Vecchio crediting changing workplaces as a driver.
The saying goes that every animal in Australia is trying to kill you. Global technology giant Google recently learned the hard way that even machines aren’t exempt from this home truth.
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. Nick Guidera, from Eley Griffiths Group, selected Aussie Broadband as one of his three favourite stocks as the company became Australia’s fastest-growing…
Under most circumstances, discussing the weather is considered something of a faux pas committed by only the poorest of conversationalists, but in the past few weeks it has dominated the national conversation.
Australian software company TZ has spent two years fine-tuning its books and offering – but its newly appointed CEO is thinking much bigger, vowing to steer the company to new heights.
Investors are unprepared for the full scale of the global semiconductor shortage’s fallout, a leading US fund manager has warned.
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. Craig Scheef, from Technical Investing, selected Peak Resources as one of his three favourite stocks as the company digs into the global…
Australian company TZ Limited is looking to capture a larger share of the growing Internet of Things market following the development of open APIs to allow third-party device control.
Investment into the so-called ‘Internet of Things’ is expected to pick up in the coming five years as businesses look for new ways to make their organisations more effective.
Prescient Therapeutics’ next-generation CAR-T platform OmniCAR has delivered overwhelmingly positive results in recent studies as the company builds towards clinical testing.
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.